On the edge: Pharmacological evidence for anxiety-related behavior in zebrafish larvae
- 1 March 2012
- journal article
- Published by Elsevier BV in Behavioural Brain Research
- Vol. 228 (1), 99-106
- https://doi.org/10.1016/j.bbr.2011.11.041
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adenosine A1, but not A2, Receptor Blockade Increases Anxiety and Arousal in ZebrafishBasic & Clinical Pharmacology & Toxicology, 2011
- Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypesNeurobiology of Disease, 2010
- Early differences in epithalamic left–right asymmetry influence lateralization and personality of adult zebrafishBehavioural Brain Research, 2010
- Rapid behavior-based identification of neuroactive small molecules in the zebrafishNature Chemical Biology, 2010
- Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake RegulationScience, 2010
- Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafishBehavioural Brain Research, 2009
- Automated analysis of behavior in zebrafish larvaeBehavioural Brain Research, 2009
- The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A 2A adenosine receptor antagonistsPsychopharmacology, 2000
- Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publicationLife Sciences, 1995
- Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the ratJournal of Neuroscience Methods, 1985